<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03935022</url>
  </required_header>
  <id_info>
    <org_study_id>Unimi_DiSAA_01</org_study_id>
    <nct_id>NCT03935022</nct_id>
  </id_info>
  <brief_title>Rice Anthocyanin Bioavailability in Humans</brief_title>
  <official_title>Anthocyanin Bioavailability and Plasma Antioxidant Capacity in Healthy Volunteers After Acute Rice Intake</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Milan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aims of the project

        1. To determine the rice anthocyanin content via high-performance liquid
           chromatographycoupled to mass spectrometry, HPLC-MS

        2. To study the oral bioavailability of anthocyanins in healthy volunteers after the intake
           of a serving (80 g) of black rice (Venere and Artemide varieties).

        3. To determine the plasma biokinetics parameters of rice anthocyanins via spectrophometric
           determination and high-performance liquid chromatographycoupled to mass spectrometry,
           HPLC-MS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To limit the interindividual variability, The protocol will be designed as a prospective,
      randomized, cross-over pharmacokinetic study on healthy volunteers. Participants will be
      randomly divided into three groups (black rice Venere, black rice Artemide and white
      rice/control) by an allocation software ( http://graphpad.com/quickcalcs/randomise1.cfm )
      which will generate different random sequences of the treatment assignment.

      Subjects will be deprived of anthocyanin-rich food sources 7 days before experimentation
      (wash-out period). Each volunteer will receive a complete list of anthocyanin-rich foods to
      be avoided, including berry fruits (i.e. blueberries, cranberries, raspberries, blackcurrants
      and elderberries), red/violet fruits/vegetables (i.e. grapes, cherries, pomegranates, red
      apples, plums, eggplants, tomatoes and peppers), red wine and other colored products (i.e.
      marmalade, jams and juices containing berries). Breakfast, lunch and dinner will be
      standardized 1 day before the experiment. Each group will randomly receive, during three
      different experimental days, one of the following treatments by different allocation
      sequences:

        1. 80g of black rice Venere (Group A)

        2. 80g of black rice Artemide (Group B)

        3. 80g of white rice (Group C)

      Therefore, each subject will be involved in three experimental days. The three treatments
      will be separated by a 7 day wash-out period.

      After an overnight fast, volunteers will consume the rice serving within 10-15 min,
      immediately after the first basal blood collection at 8:00 a.m. (baseline). Other blood
      withdrawals will be collected after 30 minutes, 1 hour, 2 hours, 3 hours.

      Chemical analyses. The extraction protocols of anthocyanins from body fluids will be
      developed, in order to reach the maximum yield of the analytes from the samples. Plasma
      anthocyanins will be measured by spectrophometric determination and high-performance liquid
      chromatographycoupled to mass spectrometry, HPLC-MS.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 6, 2019</start_date>
  <completion_date type="Actual">July 21, 2019</completion_date>
  <primary_completion_date type="Actual">May 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in plasma total anthocyanin detection</measure>
    <time_frame>0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours</time_frame>
    <description>Total anthocyanins will be detected via spectrophometric determination; expressed as μg of catechin per mL of plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in plasma Cyanidin-3-O-glucoside detection</measure>
    <time_frame>0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours</time_frame>
    <description>Cyanidin-3-O-glucoside will be detected via high-performance liquid chromatographycoupled to mass spectrometry, HPLC-MS) in plasma; expressed nM (nano molar) in plasma</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in plasma antioxidant capacity ABTS</measure>
    <time_frame>0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours</time_frame>
    <description>2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS+); the results are expressed as Trolox equivalent antioxidant capacity (TEAC, mmoleq Trolox/mL plasma)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in plasma antioxidant capacity DPPH</measure>
    <time_frame>0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours</time_frame>
    <description>2,2-diphenyl-1-picrylhydrazyl (DPPH); percentage of inhibition (I%) is calculated as [(ABScontrol 517 nm − ABSsample 517 nm/ABScontrol 517 nm)×100]</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Black rice Venere</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy volunteers will receive the black rice Venere in a cross-over randomized clinical trial (after 7 days wash-out).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Black rice Artemide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy volunteers will receive the black rice Artemide in a cross-over randomized clinical trial (after 7 days wash-out).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Complete white rice</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Healthy volunteers will receive the complete white rice in a cross-over randomized clinical trial (after 7 days wash-out).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rice</intervention_name>
    <description>Each group will randomly receive, during three different experimental days, one of the following treatments by different allocation sequences:
80g of black rice Venere (Group A)
80g of black rice Artemide (Group B)
80g of brown rice (Group C) The three treatments will be separated by a 7 day wash-out period. After an overnight fast, volunteers will consume the rice serving within 10-15 min, immediately after the first basal blood collection at 8:00 a.m. (baseline). Other blood withdrawals will be carried out a 0.5, 1.0, 2.0 and 3.0 h after rice administration.</description>
    <arm_group_label>Black rice Artemide</arm_group_label>
    <arm_group_label>Black rice Venere</arm_group_label>
    <arm_group_label>Complete white rice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy status

          -  Age: 18-45

          -  Normal weight (BMI 18.5-24.9) who voluntarily accept to join the study, after informed
             consent.

        Exclusion Criteria:

          -  &lt;18 Years;

          -  Pregnancy and lactation;

          -  Systemic disorders;

          -  Dietary supplements intake (vitamins, antioxidants, botanicals, phytochemicals)

          -  Abnormal hematological parameters;

          -  Heavy smoking and alcohol drinking;

          -  High-intensity physical activity.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcello Iriti</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Milan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Marcello Iriti</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20133</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>García-Conesa MT, Chambers K, Combet E, Pinto P, Garcia-Aloy M, Andrés-Lacueva C, de Pascual-Teresa S, Mena P, Konic Ristic A, Hollands WJ, Kroon PA, Rodríguez-Mateos A, Istas G, Kontogiorgis CA, Rai DK, Gibney ER, Morand C, Espín JC, González-Sarrías A. Meta-Analysis of the Effects of Foods and Derived Products Containing Ellagitannins and Anthocyanins on Cardiometabolic Biomarkers: Analysis of Factors Influencing Variability of the Individual Responses. Int J Mol Sci. 2018 Feb 28;19(3). pii: E694. doi: 10.3390/ijms19030694. Review.</citation>
    <PMID>29495642</PMID>
  </reference>
  <reference>
    <citation>Krga I, Milenkovic D. Anthocyanins: From Sources and Bioavailability to Cardiovascular-Health Benefits and Molecular Mechanisms of Action. J Agric Food Chem. 2019 Feb 20;67(7):1771-1783. doi: 10.1021/acs.jafc.8b06737. Epub 2019 Feb 8. Review.</citation>
    <PMID>30698008</PMID>
  </reference>
  <reference>
    <citation>Ciulu M, Cádiz-Gurrea ML, Segura-Carretero A. Extraction and Analysis of Phenolic Compounds in Rice: A Review. Molecules. 2018 Nov 6;23(11). pii: E2890. doi: 10.3390/molecules23112890. Review.</citation>
    <PMID>30404149</PMID>
  </reference>
  <reference>
    <citation>Dias ALS, Pachikian B, Larondelle Y, Quetin-Leclercq J. Recent advances on bioactivities of black rice. Curr Opin Clin Nutr Metab Care. 2017 Nov;20(6):470-476. doi: 10.1097/MCO.0000000000000417. Review.</citation>
    <PMID>28858891</PMID>
  </reference>
  <reference>
    <citation>Van Hung P. Phenolic Compounds of Cereals and Their Antioxidant Capacity. Crit Rev Food Sci Nutr. 2016;56(1):25-35. doi: 10.1080/10408398.2012.708909. Review.</citation>
    <PMID>25075608</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 17, 2019</study_first_submitted>
  <study_first_submitted_qc>April 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2019</study_first_posted>
  <last_update_submitted>April 2, 2020</last_update_submitted>
  <last_update_submitted_qc>April 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Milan</investigator_affiliation>
    <investigator_full_name>Marcello Iriti</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

